Skip to main content

Table 1 Demographic information on the recruited subjects and the indication for the enoxaparin prescription

From: Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium

Demographic Number N = 123 (%)
Ethnicity   
Caucasian 66 (54)
African-Caribbean 37 (30)
Asian 9 (7)
Other 11 (9)
Primi gravid 26 (21)
Body mass index (kg/m 2 )   
Underweight (<18.5) 2 (2)
Normal (18.5-24.9) 62 (50)
Overweight (25-29.9) 32 (26)
Obese Class I (30-34.9) 7 (6)
Obese Class II (35-39.9) 4 (3)
Obese Class III (≥40) 16 (13)
Indication for antenatal enoxaparin   
Prophylaxis of VTE 83 (68)
Treatment of VTE 9 (7)
Antiphospholipid syndrome 9 (7)
Patients converting from long term warfarin 10 (8)
Other* 12 (10)
  1. *7 patients with recurrent miscarriage in the absence of APLS, 1 patient with a history of retinal artery occlusion, 1 patient with a suspected patent foramen ovale, 1 patient with a history of a stillbirth – histology findings of the placenta reported a perivillous fibrin deposition, placental ageing and dysmaturity, 1 patient with a history of intrauterine growth retardation and abruption, 1 patient with a history of intrauterine growth retardation and pregnancy induced hypertension.